These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3447280)

  • 1. [Topical use of Rheumon-Gel in the combined treatment of patients with rheumatoid arthritis].
    Cherevatov BG; Shelest AN; Volnenko NB; Cherevatova SKh
    Ter Arkh; 1987; 59(12):100-2. PubMed ID: 3447280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical trial of the new percutaneously active antirheumatic etofenamate. Summarising report (author's transl)].
    Heindl I; Lorenz D; Sieberns S; Blumberger W
    Arzneimittelforschung; 1977; 27(6B):1357-63. PubMed ID: 144509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experiences with a new percutaneously effective antirheumatic preparation].
    Huber M
    Fortschr Med; 1977 Sep; 95(36):2209-10. PubMed ID: 334654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
    Forster PJ; McConkey B
    Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience with a locally applicable antirheumatic (author's transl)].
    Klug H
    Arzneimittelforschung; 1977; 27(6B):1350-4. PubMed ID: 336057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of three therapeutic regimens using nonsteroidal antirheumatic drugs in patients with rheumatoid arthritis.
    Pavelka K; Susta A; Kanková D; Vojtísek O
    Z Rheumatol; 1981; 40(4):165-70. PubMed ID: 7293522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etofenamate (Rheumon gel). Quickly effective, risk-reduced rheumatism therapy through cutaneous application].
    ZFA (Stuttgart); 1980 May; 56(13):939-41. PubMed ID: 6968132
    [No Abstract]   [Full Text] [Related]  

  • 8. Etofenamate levels in human serum and synovial fluid following iontophoresis.
    Bender T; Bariska J; Rojkovich B; Bálint G
    Arzneimittelforschung; 2001; 51(6):489-92. PubMed ID: 11455681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Percutaneous therapy of soft tissue rheumatic diseases. Clinical trials of the non-steroid anti-phlogistic agent Rheumon gel].
    Podzich M
    ZFA (Stuttgart); 1982 Jun; 58(16):921-4. PubMed ID: 7051600
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of pirprofen (rengasil) combined with maintenance doses of corticosteroids in rheumatoid arthritis in a double-blind multicenter trial].
    Trofimova TM; Alekberova ZS; Pokryshkin VI; Kobaladze SG; Taletene IP
    Ter Arkh; 1986; 58(7):95-7. PubMed ID: 3532404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: the eleven-year results of the Finnish rheumatoid arthritis combination therapy trial.
    Rantalaiho V; Korpela M; Hannonen P; Kautiainen H; Järvenpää S; Leirisalo-Repo M; Hakala M; Puolakka K; Julkunen H; Luosujärvi R; Möttönen T;
    Arthritis Rheum; 2009 May; 60(5):1222-31. PubMed ID: 19404945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of small-dose glucocorticoids on the course of early rheumatic arthritis].
    Suponitskaia EV; Smirnov AV; Aleksandrova EN; Novikov AA; Nasonov EL
    Klin Med (Mosk); 2004; 82(9):39-42. PubMed ID: 15540421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose prednisolone in rheumatoid arthritis: adverse effects of various disease modifying antirheumatic drugs.
    Malysheva OA; Wahle M; Wagner U; Pierer M; Arnold S; Häntzschel H; Baerwald CG
    J Rheumatol; 2008 Jun; 35(6):979-85. PubMed ID: 18412314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination therapy in early rheumatoid arthritis: the COBRA study].
    Boers M; Verhoeven AC; van der Linden S
    Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2428-32. PubMed ID: 9555126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Remission induction after pentoxifylline treatment in a patient with rheumatoid arthritis].
    Ishii O; Yamada H; Ohya S; Moriuchi E; Kase C; Ichikawa Y; Yamasaki K
    Ryumachi; 1997 Dec; 37(6):810-5. PubMed ID: 9492569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of actarit combination therapy in patients with active rheumatoid arthritis resistant to gold agents].
    Sakurai T; Iso T; Inoue H; Sano K; Takeuchi K; Takagishi K
    Ryumachi; 2001 Jun; 41(3):635-45. PubMed ID: 11505513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of glucocorticoids in rheumatoid arthritis].
    Jacobsen S
    Ugeskr Laeger; 2000 Feb; 162(6):770-2. PubMed ID: 10689949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative effectiveness of new antirheumatic drugs].
    Tsvetkova ES; Sigidin IaA
    Ter Arkh; 1980; 52(11):141-4. PubMed ID: 7008232
    [No Abstract]   [Full Text] [Related]  

  • 20. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.